Infinity Bio, Inc.

Infinity Bio is a company that provides antibody profiling services using its proprietary MIPSA (Molecular Indexing of Proteins by Self-Assembly) technology to analyze antibody reactomes—the complete set of binding interactions between antibodies and antigens. The company serves research applications including infectious disease, autoimmune disease, vaccine development, allergy research, and cancer immunotherapy by characterizing immune responses and identifying immune-related patterns across...